Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells.

Area of Science:

• Cancer Stem Cell Biology
• Neuroblastoma Pathogenesis
• Molecular Oncology

Background:

• Neuroblastoma exhibits diverse clinical behaviors, potentially linked to Cancer Stem Cells (CSCs).
• CSCs possess self-renewal and tumor-forming capabilities, contributing to treatment resistance.
• Understanding CSCs is crucial for developing targeted neuroblastoma therapies.

Purpose of the Study:

• To investigate genomic and gene expression differences between CSC-like and standard neuroblastoma cells.
• To identify key signaling pathways involved in the CSC-like phenotype in neuroblastoma.
• To explore the cross-talk between signaling pathways in CSC-like neuroblastoma cells.

Main Methods:

• Enrichment of CSC-like cells using neurosphere culture conditions.
• Comparative genomic hybridization (array-CGH) for detecting DNA copy number variations.
• Microarray analysis for genome-wide gene expression profiling.
• Quantitative reverse transcription PCR (RT-qPCR) for specific gene expression analysis.

Main Results:

• Array-CGH revealed no significant genomic differences between standard and CSC-like cells.
• Microarray analysis identified dysregulated signaling pathways (Wnt, Notch, Hh, TGF-β) associated with the CSC-like phenotype.
• Inhibition of TGF-β pathway repressors (SMAD6, SMAD7) and overexpression of Sonic Hedgehog pathway components (PTCH1, GLI1, SMO) were confirmed.
• Overexpression of CSC markers (CD133, CD15) validated CSC enrichment in neurosphere cultures.

Conclusions:

• Signaling pathways like TGF-β and Hedgehog are aberrantly activated in neuroblastoma CSCs.
• These pathways play a critical role in maintaining the CSC-like phenotype and self-renewal.
• Evidence of cross-talk among these pathways highlights their collective importance in neuroblastoma progression and potential therapeutic targeting.